According to market research company AWACS, the Indian pharmaceutical market (IPM) expanded well across all therapy categories in August, growing 12.1% in value and 4.8% in volume.
In August, IPM had sales of Rs16,239 crore.
The pharmaceutical industry has increased prices for pharmaceuticals subject to price regulation and infectious disorders associated with the monsoon thanks to the wholesale pricing index (WPI) inflation-linked price hike permitted by the government.
The categories with the fastest growth rates were cardiac (13% growth), anti-infectives (13% growth), and gastrointestinal (12% growth). Vitamin sales and anti-diabetes sales both increased by 9%.
The top three selling brands in India continue to be Abbott's Mixtard, GSK's Augmentin, and USV's Glycomet.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.